Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)

Clinical trial NCT04817189 · COMPLETED

Trial details

NCT number: NCT04817189
Sponsor: Helsinn Healthcare SA
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2021-02-01
Primary completion: 2024-07-02
Enrollment: 414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.